Tirzepatide

Description

Tirzepatide

Strength Options: 5mg
Purity: ≥98%
Form: Lyophilized powder for reconstitution
Use: For laboratory research only

Description

Tirzepatide is a novel dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It has shown potent effects on glycemic control, insulin sensitivity, and weight loss in research related to metabolic syndrome and obesity.

In preclinical and clinical studies, Tirzepatide has been investigated for:

• Enhancing glucose-dependent insulin secretion

• Appetite suppression and body weight reduction

• Delaying gastric emptying

• Improving insulin sensitivity and lipid markers

Suggested Research Protocol (for investigational use only)

• Typical Dose Range: 2.5mg to 15mg once weekly

• Protocol Duration: Studied over 8–48 weeks

• Administration: Subcutaneous (SC) injection route examined

Storage Guidelines

• Store lyophilized powder at -20°C

• After reconstitution, refrigerate at 2–8°C

• Avoid direct light and repeated freeze-thaw cycles

⚠️ Legal Disclaimer

This product is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical, veterinary, or diagnostic use. All information is provided for scientific and educational reference. By purchasing, you agree to handle this material in compliance with all applicable laws and regulations.